What is Scaffold Technology Market Scope?
According to the WHO, Cancer is the second leading cause of death with 9.6 million deaths in 2018. Scaffold technology is a branch of tissue engineering that performs 3D cell cultural assays, overcoming limitations executed upon by 2D Cell culture for various drug delivery and development process. It is primarily tissue engineering, evolving into biological alternatives, with applications for replacing, regenerating and repairing diseased or defective organs or tissues. Further, increasing preference for the regenerative technology, and rising prevalence of organ transplant for the treatment the damaged organ or tissues are few factors driving the global scaffold technology market
The Scaffold Technology market study is being classified by Type (Hydrogels, Polymeric Scaffolds, Nanofiber Based Scaffolds and Micropatterned Surface Microplates), by Application (Cancer Cell Research, Stem Cell Research, Regenerative Medicine, Tissue Engineering, Microfluidics, Cell-based assays and Others) and major geographies with country level break-up.
The global scaffold technology market is fragmented with top regional and international market players. Key players are developing innovative stem cell substrates and helping out with regenerative medicines and organogenesis modeling supporting growth of the scaffold technology market. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Scaffold Technology market throughout the predicted period.
Koninklijke DSM N.V. (Netherlands), Thermo Fisher Scientific, Inc. (United States), Arterial Remodeling Technologies S.A (France), Spine Smith, LP (United States), Orthocell Ltd. (Australia), Invivo Therapeutics Holdings Corporation (United States), Lifenet Inc. (United States), Biostage, Inc. (United States), Arsenal Medical Inc. (United States), Organogenesis, Inc. (United States) and Tissue Regenix Group Plc. ((United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are 3D Biotek LLC (United States), Molecular Matrix, Inc. (United States), ReproCELL Europe Ltd (Reinnervate) (United Kingdom) and Pelo Biotech GmbH (Germany).
Segmentation Analysis
Analyst at AMA have segmented the market study of Global Scaffold Technology market by Type, Application and Region.
On the basis of geography, the market of Scaffold Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
March 2019, Researchers from Nagasaki University and Saga University have collaborated to create scaffold-free esophageal structures with 3D bioprinting. The findings of the research were published in the paper titled, Regeneration of esophagus using a scaffold-free biomimetic structure created with biothree-dimensional printing. The results shows that “the esophagus-like scaffold-free tubular structures created using bio-3D printing could hold promise as a substitute for the repair of esophageal defects.”
March 2018, InVivo Therapeutics Holdings Corp. (NVIV) has received supplemental Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) for a second pivotal clinical study of the company’s Neuro-Spinal Scaffold in patients with acute spinal cord injury (SCI). The 20-patient randomized, controlled trial is designed to enhance the existing clinical evidence for the Neuro-Spinal Scaffold from the company’s single-arm INSPIRE study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury).
Influencing Market Trend
- 3D Printing Technology in the Scaffold Manufacturing Process
Market Drivers
- Growing Demand for Organ Transplantation
- Surging Number of Patients Suffering from Cancer Requiring Organ Transplant
- Increasing Application of Scaffolds for the Replacement and Regeneration of Defective Organs
Opportunities
- High Investment and R & D in the Tissue Engineering Sector
Restraints
- Failures Associated with 3D Cell Culture Model May hamper the Market Growth
Challenges
- High Cost Involved in Scaffold Technology for its Research Activities
Key Target Audience
Scaffold Technology Service Providers, Research Organizations, Industry Associations, Potential Investors, Government and Regulatory Bodies and Others
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.